Scilex Holding (SCLX) Interest Expenses (2021 - 2026)

Scilex Holding (SCLX) posted quarterly Interest Expenses of $3.8 million for Q1 2026, up 52.32% year-over-year from $2.5 million in Q1 2025, and up 8.03% on a QoQ basis from $3.5 million in Q4 2025.

Scilex Holding (SCLX) Interest Expenses (2021 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Interest Expenses for 6 consecutive years, with $3.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Expenses rose 52.32% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $12.8 million (up 226.02% YoY), while the FY2025 annual figure was $11.5 million, up 483.75% from the prior year.
  • Interest Expenses came in at $3.8 million for Q1 2026 at Scilex Holding, up from $3.5 million in the prior quarter.
  • The five-year high for Interest Expenses was $5.3 million in Q1 2023, with the low at $7466.0 in Q1 2022.
  • Average Interest Expenses over 5 years is $1.8 million, with a median of $1.0 million recorded in 2022.
  • Across the five-year window, Interest Expenses jumped 70513.45% in 2023 and sank 89.93% in 2024, its largest moves.
  • Year by year, Interest Expenses stood at $1.0 million in 2022, then sank by 45.34% to $551000.0 in 2023, then slumped by 48.28% to $285000.0 in 2024, then soared by 1127.37% to $3.5 million in 2025, then rose by 8.03% to $3.8 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $3.8 million, $3.5 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 272.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -393.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 657.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 240.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -343.00 Mn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn 3.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.78 Mn
Mar 31, 2026 3.78 Mn
Dec 31, 2025 3.50 Mn
Dec 31, 2025 3.50 Mn
Sep 30, 2025 2.80 Mn
Sep 30, 2025 2.80 Mn
Jun 30, 2025 2.68 Mn
Jun 30, 2025 2.68 Mn
Mar 31, 2025 2.48 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 285,000.00
Dec 31, 2024 285,000.00
Sep 30, 2024 576,000.00
Sep 30, 2024 576,000.00
Jun 30, 2024 571,000.00
Jun 30, 2024 571,000.00
Mar 31, 2024 531,000.00
Mar 31, 2024 531,000.00
Dec 31, 2023 551,000.00
Dec 31, 2023 551,000.00